SUDOSCAN+ is an innovative device for the early detection of diabetes complications. It is powered by SUDOSCAN.
SUDOSCAN+ has proven to be a reproducible and quantitative test method which is not influenced by level of glycaemia in recent clinical studies where it has performed conventional tests.
SUDOSCAN+ assesses symmetric neuropathies
Most of diabetic neuropathies are symmetric on both limbs . One of our recent clinical study has demonstrated that SUDOSCAN+ assesses symmetric neuropathies .
SUDOSCAN+ detects peripheral neuropathy of hands and feet
- Correlation coefficient between foot ESC and VPT was -0.45 (p<0.0001) 
- Correlation coefficient between foot ESC and retinopathy status was -0.42 (p<0.0001) 
SUDOSCAN+ reflects anomalies of the sympathetic nervous system
SUDOSCAN+ detects cardiac autonomic neuropathy
Electrochemical Sweat Conductance measured by SUDOSCAN+ reflects sweat function which is sympathetic dependant.
A recent study conducted in Pune, India, has demonstrated that people with ESC<40µS (abnormal ESC) have more risk to have abnormal Ewing tests which reflects cardiac autonomic neuropathy status. 
 Boulton et al.Diabetic Somatic Neuropathy. Diabetes care. 2004;27(6):1458-1486  Gin et al. Assessment of diabetic foot risk by vibration perception threshold and a simple method measuring sudomotor function. Diabetes & Metabolism. DOI: 10.1016/j.diabet.2011.05.003  Yajnik et al. Quick and simple evaluation of sudomotor function for early detection of diabetic neuropathy. Diabetic medicine. Submitted